"Use of Cannabidiol (CBD) in refractory epilepsy at a level 4 epilepsy center: An open label study" by Pooja Patel

Selected Works of Pooja Patel

Follow Contact

Presentation

Use of Cannabidiol (CBD) in refractory epilepsy at a level 4 epilepsy center: An open label study

American Epilepsy Society (2016)

Pooja Patel

Disciplines

Medicine and Health Sciences

Publication Date

2016

Citation Information

Pooja Patel. "Use of Cannabidiol (CBD) in refractory epilepsy at a level 4 epilepsy center: An open label study" American Epilepsy Society (2016)
Available at: http://works.bepress.com/pooja-patel/3/